MRI versus 64-row MDCT for diagnosis of hepatocellular carcinoma

doi:10.3748/wjg.15.6044

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 48

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3914)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-6) series, Tables (1-3) series.

Item

Count

PDF

371

HTML

3075

Figures (1-6)

280

Tables (1-3)

188

Sum=3914

Dec 28, 2009 (publication date) through Jul 21, 2024

Times Cited of This Article

Times Cited (22)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Original Article

World J Gastroenterol. Dec 28, 2009; 15(48): 6044-6051
Published online Dec 28, 2009. doi: 10.3748/wjg.15.6044

Full Size Figure Download Figure

Figure 2 70-year-old man with biopsy-proven HCC. Detection of an additional tumour nodule by MRI, size 10 mm (size category ≤ 10 mm). MDCT does not show any contrast enhancement in the arterial (A, arrow) or portal venous phase (B, arrow). MRI arterial phase depicts one more tumour nodule (C, arrow) which is hypo- to isointense on the portal venous phase (D, arrow).

Citation: Pitton MB, Kloeckner R, Herber S, Otto G, Kreitner KF, Dueber C. MRI versus 64-row MDCT for diagnosis of hepatocellular carcinoma. World J Gastroenterol 2009; 15(48): 6044-6051
URL: https://www.wjgnet.com/1007-9327/full/v15/i48/6044.htm
DOI: https://dx.doi.org/10.3748/wjg.15.6044